Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 0.307\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CC(C)(C)c1ccc(C(=O)NNC(=O)Cc2cccc3ccccc23)cc1
b) CCn1c(CSCc2ccc(C)cc2)n[nH]c1=S
c) CCC(C)C1NC(=S)N(Cc2ccccc2)C1=O
Answer: c. CCC(C)C1NC(=S)N(Cc2ccccc2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)C1NC(=S)N(Cc2ccccc2)C1=O
CCC(C)C1NC(=S)N(Cc2ccccc2)C1=O
3-benzyl-5-butan-2-yl-2-sulfanylideneimidazolidin-4-one